The U.S. Supreme Court on Monday for the second time did not announce whether it would hear an appeal by Teva Pharmaceuticals in a patent fight with generic competitors over its top-selling multiple sclerosis drug Copaxone. The nine justices are considering whether to review a July 2013 ruling by the U.S. Court of Appeals in favor of two cheaper generic forms of Copaxone by Novartis AG’s Sandoz together with Momenta Pharmaceuticals , Inc. (NASDAQ:MNTA) and Mylan jointly with Natco Pharma. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) stock performance was 8.87% in last session and finished the day at $14.36. Traded volume was 1.04million shares in the last session and the average volume of the stock remained 632.18K shares. The beta of the stock remained 1.48. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) insider ownership is 2.50%.
Orthofix International NV (NASDAQ:OFIX) Chief executive officer could not fail to point out that2013 was a transitional and challenging year for the company as it grappled with several headwinds behind the scene, while presenting fourth quarter and full year result for the period ending December 31, 2013. Orthofix International NV (NASDAQ:OFIX) rose 14.47 percent to $30.38 Thursday on volume of 1.41million shares. The intra-day range of the stock was $26.58 to $30.55. Orthofix International NV (NASDAQ:OFIX) has a market capitalization of $590.99million.
Oxygen Biotherapeutics, Inc., (NASDAQ:OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that it has priced an underwritten public offering of shares of common stock at a public offering price of $5.60 per share for gross proceeds of approximately $52 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT)’s stock on Mar 27, 2014 reported a increase of 5.16% to the closing price of $5.71. Its fifty two weeks range is $1.19 -$11.40. The total market capitalization recorded $150.97million. The overall volume in the last trading session was 660,218.00million shares. In its share capital, OXBT has 4.94million outstanding shares.
Curis Inc (NASDAQ:CRIS) had its price target reduced by Roth Capital from $10.00 to $9.00 in a research report sent to investors on Monday morning, AmericanBankingNews.comreports. On Thursday, shares of Curis, Inc. (NASDAQ:CRIS) advanced 6.32% to close the day at $2.86. Company return on investment (ROI) is -12.40% and its monthly performance is recorded as -11.73%. Curis, Inc. (NASDAQ:CRIS) quarterly revenue growth is 1.06%.